128 related articles for article (PubMed ID: 25513028)
1. CD4 counts in laboratory monitoring of HIV disease--experience from western India.
Ingole N; Nataraj G; Mehta P; Paranjpe S; Sarkate P
J Int Assoc Provid AIDS Care; 2014; 13(4):324-7. PubMed ID: 25513028
[TBL] [Abstract][Full Text] [Related]
2. CD4 counts in laboratory monitoring of HIV disease--experience from western India.
Ingole N; Nataraj G; Mehta P; Paranjpe S; Sarkate P
J Int Assoc Provid AIDS Care; 2014; 13(4):324-7. PubMed ID: 23442562
[TBL] [Abstract][Full Text] [Related]
3. Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.
Gitura B; Joshi MD; Lule GN; Anzala O
East Afr Med J; 2007 Oct; 84(10):466-72. PubMed ID: 18232267
[TBL] [Abstract][Full Text] [Related]
4. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.
Obirikorang C; Quaye L; Acheampong I
BMC Infect Dis; 2012 Jun; 12():128. PubMed ID: 22676809
[TBL] [Abstract][Full Text] [Related]
5. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries.
Kumarasamy N; Mahajan AP; Flanigan TP; Hemalatha R; Mayer KH; Carpenter CC; Thyagarajan SP; Solomon S
J Acquir Immune Defic Syndr; 2002 Dec; 31(4):378-83. PubMed ID: 12447007
[TBL] [Abstract][Full Text] [Related]
6. Use of total lymphocyte count to predict absolute CD4 count in HIV-seropositive cases.
Gautam H; Saini S; Bhalla P; Singh T
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):292-5. PubMed ID: 20923954
[TBL] [Abstract][Full Text] [Related]
7. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.
Oudenhoven HP; Meijerink H; Wisaksana R; Oetojo S; Indrati A; van der Ven AJ; van Asten HA; Alisjahbana B; van Crevel R
Trop Med Int Health; 2011 Nov; 16(11):1372-9. PubMed ID: 21883724
[TBL] [Abstract][Full Text] [Related]
8. Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients.
van der Ryst E; Kotze M; Joubert G; Steyn M; Pieters H; van der Westhuizen M; van Staden M; Venter C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):238-44. PubMed ID: 9803965
[TBL] [Abstract][Full Text] [Related]
9. Disease progression and antiretroviral therapy in newly seropositive HIV subjects in a tertiary care hospital in North India.
Chadha S; Bhalla P; Jha AK; Gautam H; Saini S; Anuradha S; Dewan R
J Infect Dev Ctries; 2013 Feb; 7(2):110-5. PubMed ID: 23416656
[TBL] [Abstract][Full Text] [Related]
10. Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India.
Rajasekaran S; Jeyaseelan L; Raja K; Vijila S; Krithigaipriya KA; Kuralmozhi R
J Postgrad Med; 2009; 55(4):261-6. PubMed ID: 20083872
[TBL] [Abstract][Full Text] [Related]
11. Use of surrogate markers to predict the HIV disease stage and time to initiate antiretroviral therapy in developing countries.
Chaudhary M; Kashyap B; Gautam H; Saini S; Bhalla P
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(5):259-64. PubMed ID: 18780895
[TBL] [Abstract][Full Text] [Related]
12. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
Susaengrat W; Mitchai M; Leerattanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
[TBL] [Abstract][Full Text] [Related]
13. Total lymphocyte count as a tool for timing opportunistic infection prophylaxis in resource-limited settings: a study from India.
Srirangaraj S; Venkatesha D
J Infect Dev Ctries; 2010 Oct; 4(10):645-9. PubMed ID: 21045357
[TBL] [Abstract][Full Text] [Related]
14. Validity of existing CD4+ classification in north Indians, in predicting immune status.
Attili VS; Sundar S; Singh VP; Rai M
J Infect; 2005 Jul; 51(1):41-6. PubMed ID: 15979490
[TBL] [Abstract][Full Text] [Related]
15. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
16. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
[TBL] [Abstract][Full Text] [Related]
17. CD4 counts of normal and HIV-infected south Indian adults: do we need a new staging system?
Ramalingam S; Kannangai R; Zachariah A; Mathai D; Abraham C
Natl Med J India; 2001; 14(6):335-9. PubMed ID: 11804363
[TBL] [Abstract][Full Text] [Related]
18. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
Spacek LA; Griswold M; Quinn TC; Moore RD
AIDS; 2003 Jun; 17(9):1311-7. PubMed ID: 12799552
[TBL] [Abstract][Full Text] [Related]
19. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
Shah I; Parikh S
J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
[TBL] [Abstract][Full Text] [Related]
20. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?
Mbanya D; Assah F; Ndembi N; Kaptue L
Int J Infect Dis; 2007 Mar; 11(2):157-60. PubMed ID: 16762583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
